IMCL did not change with surgery (21, 93) or in pegvisomant-treated acromegaly patients vs. controls (94) but did decrease with the addition of pegvisomant to SRL therapy (95) and correlated inversely with insulin sensitivity in a combined acromegaly and control cohort (94). This evidence concerns the gene INS and acromegaly.